PIONEER - Big Data in Prostate Cancer

PIONEER+ and the EAU UroEvidenceHub organise their first Hackathon! During the course of IMI-PIONEER, we learnt that getting together for a multi-day intensely focused event is one of the best ways to accelerate our collaborative work. It allows us to experience the true sense of collaboration, learn from one another, create strong connections and ultimately to work more efficiently.   So, we have organised a Hackathon! We are gathering a multi-disciplinary group of clinicians, programmers and statisticians to progress the software development work that had started during IMI-PIONEER and that is now continuing under PIONEER+ within the EAU UroEvidenceHub.   The Hackathon is taking place on 9-12 April and we are delighted to be hosted by Bayer’s #LifeHubLyon #Bayer #European Association of Urology

PIONEER+ is kicking-off! IMI-PIONEER has formally ended in October 2023. Over the 5.5 years, we have accomplished a lot, but we are only just getting started. PIONEER will continue its activities as PIONEER+, embedded in Foundation EAU UroEvidenceHub.   We are excited to announce that PIONEER+ will launch at EAU24. Among else, we plan to: 1. Revisit PIONEER’s achievements and discuss how best to build on them. 2. Discuss our shared vision and how we will achieve it. 3. Review our way of working and move towards kicking-off new exciting research collaborations. 4. Reconnect with dear friends and colleagues.   We are looking forward to seeing many of you at EAU24 in Paris and are excited to update you on our next steps.   Cannot attend but are interested to learn more about ways of contributing? Get in touch with us via [email protected].

📢 Take a look at our latest article published in European Urology Open Science! Read more about how can we improve patient-clinician communication for men diagnosed with #ProstateCancer? PIONEER - Big Data in Prostate Cancer To the article: 👇 👇 👇 https://lnkd.in/evJAH37F

📢 Take a look at our latest article published in European Urology Open Science! Read more about how can we improve patient-clinician communication for men diagnosed with #ProstateCancer? PIONEER - Big Data in Prostate Cancer To the article: 👇 👇 👇 https://lnkd.in/evJAH37F

📢 IDEAL4OMOP training programme is starting and recruiting! The IQVIA-DIGICORE Early Career Leadership Programme for OMOP, ‘IDEAL4OMOP’, has been developed by DIGICORE, and supports its vision to enable precision oncology research at scale across Europe.    The programme has been designed in light of DIGICORE’s recent success in being awarded a substantial Interregional Innovation Investment (I3) grant by the European Regional Development Fund (ERDF) to build an international network of hospitals with a cancer research dataset conformed to the standards of the OHDSI OMOP Common Data Model.    This multi-year programme will build research leadership skills in OMOP, and give trainees the opportunity to build an international study team, design a research project, and apply for funding. Participants should ideally be earlier in their career (< 45 years old) with a strong interest in digital research in cancer – clinician researchers are welcome to apply, as are data scientists, pathologists, research managers or others interested in becoming a cancer research leader of the future.   Interested in joining? Don’t miss out on an introductory seminar on Feb 15 at 17:00 CET, and to register, please contact [email protected]. 

📢 Take a look at our latest article published in European Urology Open Science! Learn more about the Survivorship Data in #ProstateCancer: Where Are We and Where Do We Need To Be? PIONEER - Big Data in Prostate Cancer #BigData To the article: 👇👇👇 https://lnkd.in/ehDwKMtR

Thank you for your interest in PIONEER - Big Data in Prostate Cancer! We look forward to a fruit-bringing cooperation within PIONEER+ also in 2024! 🤝🥳 Together, we seek to transform the field of #prostatecancer care through leveraging the potential of #BigData. #RealWorldData, #RWE.

📢 The PIONEER - Big Data in Prostate Cancer project has officially ended in October 2023, celebrating five years of successes in #BigData analysis, laying the basis to revolutionise prostate cancer research. 🎉👏👍 A team of key opinion leaders, healthcare providers and patients set out to identify prioritised research questions critical to all stakeholders, out of which the top five questions about the diagnosis and management of #ProstateCancer were prioritised. Research questions (RQ) were and are being addressed by 14 active RQ teams through the analysis of #BigData. Three of the RQs made significant progress as part of the three PIONEER Studyathons. PIONEER developed a common vocabulary, defined Core Outcome Sets, systematically reviewed both clinician-reported outcomes and psychometric properties of Patient-Reported Outcome Measures and recommended minimum sets of clinician and patient-reported outcomes for use in routine practice and research settings. Lastly, an Online Search Tool for Diagnostic and Prognostic Factors was developed. 🎉👋🎉 We are excited to inform you that PIONEER will continue as PIONEER+ and be integrated into the EAU´s UroEvidenceHub initiative as the prostate cancer research and support hub. 🤝🎉🎉 It is not the end; our journey is just beginning! Read more here: 👇👇👇 https://lnkd.in/dyiHJhNv

📢 PIONEER - Big Data in Prostate Cancer ended in October 2023 and will continue as PIONEER+. Read more about our achievements and: ✅New collaborations ✅New publications ✅The 3rd Studyathon ✅ New video interviews ✅ The final General Assembly Meeting ✅ The project´s highlights and Key Achievements & ✅ Plans for the future. 👉 https://lnkd.in/dEs2N-bq

Don`t miss the #BigData #Analytics for Health and Medicine (BDA4HM 2023) 2nd International Workshop at the IEEE Big Data 2023 in Sorrento, Italy, on 15-18 December! https://ow.ly/8oP350QhLaN